FDS names new CEO
Pharmacy technology company FDS has new leadership. The Fort Worth, Texas-based company on Monday named Adam McMullin CEO, effective immediately. McMullin — who has leadership experience in healthcare IT — succeeds FDS’ seven-year CEO Jake Canova, who the company will continue on in an advisory capacity.
“We are very pleased to partner with Adam to lead FDS,” said Michael Booth, a partner with FDS majority shareholder Calvert Street Capital Partners. “His broad experience in healthcare IT will be invaluable as the company continues to innovate and grow in pharmacy technology and beyond.”
McMullin joins the company from Voalte, where he was chairman and CEO . he also has led Hill-Rom’s clinical workflow solutions business, doubling the unit’s revenues and improving earnings within five years. He spent more than a decade at IBM in various management roles.
“FDS has built a strong reputation in the market based on its team’s deep commitment to customer success and its unique solutions that help ensure patients are getting the medications they need while improving pharmacy efficiency and profitability,” said McMullin. “Pharmacies represent a key part of our health system, playing a critical role in improving wellness within communities. While we will continue delivering high-value solutions and outstanding services to pharmacies, we also see many opportunities for innovations that will further help pharmacies and improve population health. I look forward to building on FDS’s leadership position and continuing to grow the business.
“We are very pleased to partner with Adam to lead FDS,” said Michael Booth, a partner with FDS majority shareholder Calvert Street Capital Partners. “His broad experience in healthcare IT will be invaluable as the company continues to innovate and grow in pharmacy technology and beyond.”
McMullin joins the company from Voalte, where he was chairman and CEO . he also has led Hill-Rom’s clinical workflow solutions business, doubling the unit’s revenues and improving earnings within five years. He spent more than a decade at IBM in various management roles.
“FDS has built a strong reputation in the market based on its team’s deep commitment to customer success and its unique solutions that help ensure patients are getting the medications they need while improving pharmacy efficiency and profitability,” said McMullin. “Pharmacies represent a key part of our health system, playing a critical role in improving wellness within communities. While we will continue delivering high-value solutions and outstanding services to pharmacies, we also see many opportunities for innovations that will further help pharmacies and improve population health. I look forward to building on FDS’s leadership position and continuing to grow the business.